Advertisement
Screener

ENVOY MEDICAL, INC. (COCH) Overview

ENVOY MEDICAL, INC. (COCH) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -0.07; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.08; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.35; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -0.32; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$0.37$0.50$0.68$0.91$1.24$1.672025-09-292026-09-29$0.37$0.73$1.44$2.84$5.59$11.022021-09-292026-09-29$0.37$0.73$1.44$2.84$5.59$11.022021-04-292026-09-29$0.37$0.73$1.44$2.84$5.59$11.022021-04-292026-09-29$0.37$0.73$1.44$2.84$5.59$11.022021-04-292026-09-29

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$0.71
Previous close
$0.69
Change
$0.02
Change (%)
2.46%
Close date
2026-09-29
Previous close date
2026-09-28
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

COCH
+7.28%
S&P 500
(m)

1 year

COCH
-11.50%
S&P 500
(m)

3 years

COCH
-89.91%
S&P 500
(m)

5 years

COCH
-92.71%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -0.07

-0.43-0.29-0.16-0.020.1131 Mar 2025: estimate (m); actual -0.2931 Mar 2025(m)30 Jun 2025: estimate (m); actual -0.3230 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.3530 Sept 2025(m)31 Mar 2026: estimate (m); actual -0.0831 Mar 2026(m)30 Jun 2026: estimate (m); actual -0.0730 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-0.07(m)(m)
1 Jan 202631 Mar 2026(m)-0.08(m)(m)
1 Jul 202530 Sept 2025(m)-0.35(m)(m)
1 Apr 202530 Jun 2025(m)-0.32(m)(m)
1 Jan 202531 Mar 2025(m)-0.29(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -1.23

-2.62-2.23-1.83-1.44-1.0531 Dec 2022: estimate (m); actual -1.5731 Dec 2022(m)31 Dec 2023: estimate (m); actual -2.5431 Dec 2023(m)31 Dec 2024: estimate (m); actual -1.4931 Dec 2024(m)31 Dec 2025: estimate (m); actual -1.2331 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-1.23(m)(m)
1 Jan 202431 Dec 2024(m)-1.49(m)(m)
1 Jan 202331 Dec 2023(m)-2.54(m)(m)
1 Jan 202231 Dec 2022(m)-1.57(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 0.05M ■ Earnings -5.98M — Profit margin -11729.41%

-7.27M-15434.3%-4.56M-12720.8%-1.85M-10007.4%0.87M-7293.9%30 Jun 2025: revenue 0.08M; earnings -5.69M; profit margin -7294.87%30 Jun 202530 Sept 2025: revenue 0.04M; earnings -6.48M; profit margin -15433.33%30 Sept 202531 Mar 2026: revenue 0.04M; earnings -4.35M; profit margin -11156.41%31 Mar 202630 Jun 2026: revenue 0.05M; earnings -5.98M; profit margin -11729.41%30 Jun 2026

31 Dec 2025 ■ Revenue 0.24M ■ Earnings -23.76M — Profit margin -9857.26%

-33.55M-9858.3%-21.05M-8811.4%-8.55M-7764.5%3.94M-6717.6%31 Dec 2022: revenue 0.24M; earnings -15.92M; profit margin -6718.57%31 Dec 202231 Dec 2023: revenue 0.32M; earnings -29.92M; profit margin -9468.99%31 Dec 202331 Dec 2024: revenue 0.23M; earnings -20.80M; profit margin -9242.22%31 Dec 202431 Dec 2025: revenue 0.24M; earnings -23.76M; profit margin -9857.26%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$0.71(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$0.71High(m)Average(m)Low(m)2025-09-292026-09-29

Recent news

View more →

(m)

YouTube videos mentioning COCH

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-23.40M
Profit margin
-11304.83%
Return on assets · 12 month
-138.27%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
57.73K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-0.84%*
Total return · month
2.75%*
Total return · quarter
4.12%*
Total return · half year
8.93%*
Total return · year to date
7.28%*
Total return · 1 year
-11.50%*
Total return · 3 years
-89.91%*
Total return · 5 years
-92.71%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$207.00K
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

ENVOY MEDICAL, INC. Overview

View more →

(m)

(m)

SEC CIK
1840877
Industry (SIC)
3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies
Country of operation
United States
Business address
4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE, Minnesota, 55110, United States
Fiscal year end
1231
Phone
651-361-8000

Similar stocks

Stock NameCountryMarket CapPE Ratio
ALPHA PRO TECH LTD (APT)$0.052B13.63
MYOMO, INC. (MYO)United States$0.065B-2.85
MILESTONE SCIENTIFIC INC. (MLSS)United States$0.036B-6.85
Safe Pro Group Inc. (SPAI)United States$0.090B
Lifeward Ltd. (LFWD)$0.021B
ENvue Medical, Inc. (FEED)United States$0.011B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
NutriBand Inc. (NTRB)United States$0.109B
Bone Biologics Corp (BBLG)United States$0.001B
Conexeu Sciences Inc. (CNXU)United States$0.111B